Pet Scan

A PET scan, short for positron emission tomography, is an imaging test that shows metabolic or biologic activity in tissues rather than only anatomy. It is often combined with CT, and in some settings MRI, to help localise areas of abnormal uptake more precisely. ^[1][2][3][4]

What is a PET scan, and how does it work?

In a typical PET study, a small amount of radioactive tracer is administered, and areas that use or process the tracer more actively may appear more prominent on the scan. The most familiar example is FDG PET, which reflects glucose-related uptake, but different tracers exist for different clinical questions. A PET scan therefore does not simply “show cancer”; it shows patterns of tracer activity that must be interpreted in context. ^[1][2][4]

That distinction is crucial. Increased uptake may reflect tumour, but it can also be seen with inflammation, infection, healing, or other biologic processes. Likewise, not every cancer is strongly visible on every PET tracer. ^[2][3][5]

Why might a PET scan be ordered?

PET may be used in oncology for staging, assessing response to therapy, clarifying equivocal findings on other imaging, investigating possible recurrence, or helping guide treatment planning. In some non-oncologic settings it can also be used for neurologic or cardiac questions. Whether it is appropriate depends on the exact disease, the timing, and what decision the imaging is expected to change. ^[1][2][4][5]

The most practical question is not “Can PET find something?” but “Will PET answer a question that changes management?” When that answer is yes, it can be a very powerful test. ^[2][3][5]

Preparation before the scan

Preparation varies by tracer, but fasting, blood-glucose considerations, hydration, activity restrictions, and timing instructions are common, especially for FDG studies. Patients with diabetes often need tailored guidance. Following preparation instructions matters because incorrect glucose handling, recent strenuous exercise, or timing problems can make images harder to interpret. ^[1][2][4]

What happens during the PET scan?

After tracer administration and an uptake period, the patient lies still while the images are acquired. The scan itself is usually not painful, though the process may feel lengthy. The need to stay still, the fasting period, and the waiting time often cause more concern than the imaging itself. ^[2][4][5]

Radiation, limits, and false positive / false negative results

PET involves exposure to ionising radiation from the tracer and, if combined with CT, from the CT component as well. The amount is generally considered acceptable when the test is appropriately indicated, but it is still not a casual or harmless imaging choice. The benefits must justify the exposure. ^[1][2][5]

The test also has important limits. False positives can occur with inflammation, infection, or healing tissues. False negatives can occur if the tumour is too small, has low tracer uptake, or if timing and biology make the lesion less visible. This is why PET should not be treated as an all-knowing scan. It is powerful, but it is still one piece of the diagnostic puzzle. ^[2][3][4]

How are results interpreted, and what do they change?

PET findings are interpreted together with anatomy, clinical history, pathology, prior treatment, and other imaging. An abnormal uptake area does not automatically mean active cancer, and a normal result does not automatically rule out every important problem. The value of the scan lies in whether it clarifies disease extent, supports or changes treatment, or helps explain uncertain findings. ^[1][2][5]